AEterna Zentaris to Present at Upcoming Bio Investor Forum in San Francisco and Bio Contact in Quebec City
September 27 2006 - 8:00AM
PR Newswire (US)
QUEBEC CITY, Sept. 27 /PRNewswire-FirstCall/ -- AEterna Zentaris
Inc. (TSX: AEZ; Nasdaq: AEZS) today announced that Gilles Gagnon,
President and Chief Executive Officer of the Company, will present
a corporate update at Bio Contact on Thursday, October 5, 2006, at
9:30 a.m. ET, in the Frontenac Room of the Fairmont Le Chateau
Frontenac Hotel in Quebec City, Canada. Mr. Gagnon will also
present a corporate update at Bio Investor Forum on Wednesday,
October 18, 2006 at 1:00 p.m. Pacific Time, in the Twin Peaks South
Room of the Palace Hotel in San Francisco. A live webcast of this
presentation will be available on AEterna Zentaris' website at
http://www.aeternazentaris.com/ in the Investors section. A replay
will also be available for a period of 60 days. About AEterna
Zentaris Inc. AEterna Zentaris Inc. is a growing global
biopharmaceutical company focused on endocrine therapy and
oncology, with proven expertise in drug discovery, development and
commercialization. AEterna Zentaris also owns 48.3% of the equity
of Atrium Biotechnologies Inc. (TSX: ATB) and 64.7% of its voting
rights. Atrium is a developer, manufacturer and marketer of
science-based products for the cosmetics, pharmaceutical, chemical
and nutritional industries. News releases and additional
information are available at http://www.aeternazentaris.com/.
DATASOURCE: AETERNA ZENTARIS INC. (FORMERLY/ANCIENNEMENT - LES
LABORATOIRES AETERNA LABORATORIES INC.) CONTACT: Media Relations:
Paul Burroughs, (418) 652-8525 ext. 406, ; Investor Relations:
Jenene Thomas, (418) 655-6420 or (908) 996-3154,
Copyright